Fig. 5

Antitumor therapeutic efficacy of siRNA@CPG@Gold Nanoshell in vivo. a The images of mice tumors treated with different ways as above description. b Tumor volume of mice-bearing MFC tumors under different treatments as above described. c Tumor weights of mice-bearing MFC tumors in different groups on the 16th day after injection. d Body weights of mice bearing MFC tumors in different groups. e The 16-day survival rates of mice after different administration. f H&E stained images of tumor, heart, liver, spleen and kidney sections collected from different treatment groups. Data are given as mean ± SD (n = 5). *P < 0.05